C12Y 204/99008
Alpha-n-acetylneuraminate alpha-2,8-sialyltransferase
Official title: Alpha-N-acetylneuraminate alpha-2,8-sialyltransferase (2.4.99.8)
C12Y204/99008 (Alpha-n-acetylneuraminate alpha-2,8-sialyltransferase) appears on 0 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 0
- Published applications
- 4
- Assignees
- 2
- Inventors
- 17
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
By publication year.
Recent patents
No granted patents in this class yet.
- Synthesis of c-glycosides of interest5 Oct 2023US 2023/0313248 A1
- Cells Highly Sensitive to Clostridial Neurotoxin13 Oct 2022US 2022/0326221 A1Synaptic Research, LLC
- Polysialic acid, blood group antigens and glycoprotein expression in prokaryotes4 Feb 2016US 2016/0032344 A1Glycobia, Inc.
- Polysialic acid, blood group antigens and glycoprotein expression in prokaryotes18 Sep 2014US 2014/0273103 A1Glycobia, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.